Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Chopra

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
The Journal of Antimicrobial Chemotherapy|November 9, 2012
The 2012 Garrod lecture: discovery of antibacterial drugs in the 21st centuryIan Chopra
Expert Review of Anti-Infective Therapy|October 16, 2004
Antibiotic resistance in Staphylococcus aureus: concerns, causes and curesIan Chopra
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 19, 2002
New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitorsIan Chopra
The Journal of Antimicrobial Chemotherapy|February 20, 2007
The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern?Ian Chopra
Current Opinion in Investigational Drugs (London, England : 2000)|August 2, 2007
Bacterial RNA polymerase: a promising target for the discovery of new antimicrobial agentsIan Chopra
The Journal of Antimicrobial Chemotherapy|August 6, 2002
Insertional inactivation of mutS in Staphylococcus aureus reveals potential for elevated mutation frequencies, although the prevalence of mutators in clinical isolates is lowAlexander J O'Neill, Ian Chopra
Molecular Microbiology|January 5, 2006
Molecular basis of fusB-mediated resistance to fusidic acid in Staphylococcus aureusAlexander John O'Neill, Ian Chopra
Expert Opinion on Investigational Drugs|July 23, 2004
Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniquesAlex J O'Neill, Ian Chopra
Antimicrobial Agents and Chemotherapy|December 25, 2003
Escherichia coli mutators present an enhanced risk for emergence of antibiotic resistance during urinary tract infectionsKeith Miller, Alexander John O'Neill, Ian Chopra
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 16, 2003
The role of mutators in the emergence of antibiotic-resistant bacteriaIan Chopra, Alexander J O'Neill, Keith Miller
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|November 9, 2012
The 2012 Garrod lecture: discovery of antibacterial drugs in the 21st centuryIan Chopra
Expert Review of Anti-Infective Therapy|October 16, 2004
Antibiotic resistance in Staphylococcus aureus: concerns, causes and curesIan Chopra
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 19, 2002
New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitorsIan Chopra
The Journal of Antimicrobial Chemotherapy|February 20, 2007
The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern?Ian Chopra
Current Opinion in Investigational Drugs (London, England : 2000)|August 2, 2007
Bacterial RNA polymerase: a promising target for the discovery of new antimicrobial agentsIan Chopra
The Journal of Antimicrobial Chemotherapy|August 6, 2002
Insertional inactivation of mutS in Staphylococcus aureus reveals potential for elevated mutation frequencies, although the prevalence of mutators in clinical isolates is lowAlexander J O'Neill, Ian Chopra
Molecular Microbiology|January 5, 2006
Molecular basis of fusB-mediated resistance to fusidic acid in Staphylococcus aureusAlexander John O'Neill, Ian Chopra
Expert Opinion on Investigational Drugs|July 23, 2004
Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniquesAlex J O'Neill, Ian Chopra
Antimicrobial Agents and Chemotherapy|December 25, 2003
Escherichia coli mutators present an enhanced risk for emergence of antibiotic resistance during urinary tract infectionsKeith Miller, Alexander John O'Neill, Ian Chopra
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 16, 2003
The role of mutators in the emergence of antibiotic-resistant bacteriaIan Chopra, Alexander J O'Neill, Keith Miller
Pageof 6